Clinical and experimental studies on stomach carcinoma treated with Yangwei Kangliu granules

Table 2 Change in T lymphocyte subset between the Yangwei Kangliu + chemotherapy (treatment) and chemotherapy only (control) group

Group	n	CD3	CD4	CD8	CD4/CD8
Treatment group
Pre-treatment	50	66.00 ± 6.81	38.00 ± 4.52	32.36 ± 2.91	11.23 ± 0.166
Post-treatment	50	66.27 ± 5.55	39.00 ± 4.15	26.45 ± 2.84b	1.48 ± 0.156b
Control group
Pre-treatment	20	63.59 ± 8.32	38.18 ± 6.7	31.56 ± 2.82	1.26 ± 0.22
Post-treatment	20	62.18 ± 9.03	36.37 ± 3.39	32.47 ± 4.89d	1.21 ± 0.2d

^bP < 0.01, Compared with the treatment group in pre-treatment;

^dP < 0.01, Compared with the treatment group in post-treatment.